1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Neuropathological findings in Down syndrome, Alzheimer's disease and control patients with and without SARS-COV-2 : preliminary findings
(
- Contribution to journal › Article
- 2022
-
Mark
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer's disease continuum
(
- Contribution to journal › Article
-
Mark
Medial Temporal Lobe Networks in Alzheimer's Disease : Structural and Molecular Vulnerabilities
2022) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 42(10). p.2131-2141(
- Contribution to journal › Article
-
Mark
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
(
- Contribution to journal › Article
- 2020
-
Mark
Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease
(
- Contribution to journal › Article
- 2019
-
Mark
In vivo measures of tau burden are associated with atrophy in early Braak stage medial temporal lobe regions in amyloid-negative individuals
(
- Contribution to journal › Article
-
Mark
α-synuclein in the pathophysiology of Alzheimer's disease
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake
(
- Contribution to journal › Article
-
Mark
Early Tau Burden Correlates with Higher Rate of Atrophy in Transentorhinal Cortex
(
- Contribution to journal › Article
- 2013
-
Mark
Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease
(
- Contribution to journal › Article